In 2024, Sobi's operating profit (EBIT) stood at 4.07 billion Swedish kronor. Swedish biopharmaceutical company Sobi had a negative EBIT during the period from 2011 to 2014, but over the following years, it increased significantly, and in 2024 Sobi's operating profit was around 5.6 billion Swedish kronor, the highest amount so far. The company's full name is Swedish Orphan Biovitrum AB. Sobi is specialized on the treatment of rare diseases.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Sobi, & Nasdaq Nordic. (March 31, 2025). Operating profit (EBIT) of Sobi from 2009 to 2024 (in million SEK) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 25, 2026, from /statistics/946954/operating-profit-of-sobi/
Sobi, und Nasdaq Nordic. "Operating profit (EBIT) of Sobi from 2009 to 2024 (in million SEK)." Chart. March 31, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 25, 2026. /statistics/946954/operating-profit-of-sobi/
Sobi, Nasdaq Nordic. (2025). Operating profit (EBIT) of Sobi from 2009 to 2024 (in million SEK). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 25, 2026. /statistics/946954/operating-profit-of-sobi/
Sobi, and Nasdaq Nordic. "Operating Profit (Ebit) of Sobi from 2009 to 2024 (in Million Sek)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 31 Mar 2025, /statistics/946954/operating-profit-of-sobi/
Sobi & Nasdaq Nordic, Operating profit (EBIT) of Sobi from 2009 to 2024 (in million SEK) ÌÇÐÄÆƽâ°æ, /statistics/946954/operating-profit-of-sobi/ (last visited July 25, 2026)
Operating profit (EBIT) of Sobi from 2009 to 2024 (in million SEK) [Graph], Sobi, & Nasdaq Nordic, March 31, 2025. [Online]. Available: /statistics/946954/operating-profit-of-sobi/
